Pharma

parkinsons-disease11

Aus pharma benefit scheme includes Parkinson's drug

  • Australia
  • |
  • News

Singapore: The Australian Pharmaceutical Benefits Scheme has listed a novel treatment for Parkinson's disease in order to make it available for tens of thousands of Australian patients. This new treatment provides a daily patch to be... Read more

good-news-for-alzheimer-s-disease-patients-shasun-and-debiopharm-will-manufacture-brain-drug-huperzine-a

Japan approves Avastin for brain cancer treatment


  • Japan
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Roche announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Avastin (bevacizumab)... Read more

j-j-acquires-aragon-and-its-androgen-receptor-antagonist-program-including-cancer-drug-arn-509-a-second-generation-androgen-receptor-signaling-inhibitor-currently-in-phase-ii-trial

J&J to acquire cancer drug firm for $1 bn


  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Johnson & Johnson is going to acquire US-based Aragon Pharmaceuticals for $650 million in cash up front along... Read more

valeant-pharma-will-use-usd4

Valeant to acquire Bausch + Lomb for $8.7 bn cash

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Valeant Pharmaceuticals is going to acquire Bausch + Lomb Holdings for $8.7 billion in cash. Under terms of the agreement, approximately... Read more

the-japanese-government-astellas-eisai-daiichi-sankyo-shionogi-takeda-and-bill-melinda-gates-foundation-will-initiate-an-effort-worth-usd100-million-to-tackle-hiv-malaria-tuberculosis-and-tropical-diseas

Japan's top 5 bio firms fund $100 mn HIV, TB research

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Japan's top pharma companies, including Astellas, Eisai, Daiichi Sankyo, Shionogi, and Takeda, have come together to initiate... Read more

bayer-received-antitrust-clearance-from-us-federal-trade-commission-ftc-to-acquire-conceptus

Bayer gets US antitrust nod to acquire Conceptus

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Biopharmaceutical company, Bayer, has received antitrust clearance from US Federal Trade Commission (FTC) with respect to acquisition... Read more

amgen-and-astellas-pharma-enter-a-strategic-alliance-to-develop-and-commercialize-five-amgen-pipeline-medicines-in-japan

Amgen & Astellas form JV, will co-develop biologics

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: US-based Amgen and Japanese firm Astellas Pharma have entered into a strategic alliance to co-develop and co-commercialize five... Read more

hope-for-diabetes-patients-mitsubishi-tanabe-pharma-seeks-approval-of-ta-7284-canagliflozin-a-sodium-glucose-co-transporter-2-sglt2-inhibitor-in-japan

Mitsubishi Tanabe files NDA for Canagliflozin

  • Japan
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Mitsubishi Tanabe Pharma announced that the company has submitted an application for the manufacturing and marketing approval... Read more

ms-ziena-jalil-new-zealand-trade-commissioner-to-singapore-singapore

Ziena Jalil: NZ, Singapore have much to learn from each other

  • New Zealand
  • |
  • Influencers
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

New Zealand Trade and Enterprise (NZTE) is New Zealand government's national economic development agency and works to stimulate economic... Read more

whistleblower-mr-keith-schenker-who-is-a-former-sales-representative-of-ista-will-receive-usd2

Ista Pharma to pay $33 mn for illegal drug promotion

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: US-based Ista Pharmaceuticals will pay $33.5 million to settle criminal and civil liability, after the company pleaded guilty... Read more

sun-pharma-s-branded-generic-sales-in-india-alone-were-usd156-million

Sun Pharma net sales rise 32%, will issue 1:1 bonus

  • India
  • |
  • Company Results
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Mumbai: Sun Pharmaceutical Industries reported financials for the fourth quarter and year ending March 31st, 2013. The firm's net sales... Read more

will-the-recent-controversies-surrounding-ranbaxy-and-wockhardt-hamper-the-strong-foothold-that-indian-pharma-has-established-over-the-past-two-decades-in-western-markets

Will Ranbaxy, Wockhardt incidents affect brand India?

  • India
  • |
  • Analysis
  • |
  • By Sheetal Sukhija
  • |
  • 0 Comment

When the Indian generic sector forayed into the global arena almost two decades back, the affordability of its treatment options and its... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X